Italy, China, U.S. most likely determine cases the same way so far. No wonder CFR is similar. However, these tests are limited compared to serologic tests:
> The test kits in use in the U.S. described in the articles detect viral genetic material—RNA, in the case of coronaviruses—which can be infectious material or noninfectious fragments. Once the patient has recovered and the RNA has been cleared, the tests will be negative. If we’re trying to ascertain what proportion of the population has been infected and experienced asymptomatic, mild or more serious infections, such post-infection testing yields “false negatives.”
> Additional, essential information will need to come from “serological tests” that measure antibodies in blood, which will tell us whether a person has been recently infected with SARS-CoV-2 and recovered. (Note that antibodies take about 10-14 days from exposure to the virus to appear.)
https://www.wsj.com/articles/do-antibody-testing-to-understa...
http://archive.vn/SJkJu
> The mortality rate is thought to be ≤2%, but precise numbers uncertain due to a lack of available serological testing.
https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX...